NCT03652792View on ClinicalTrials.gov

Bioequivalence Study of Azilsartan Tablets in Chinese Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 22, 2018

Primary Completion Date

June 25, 2018

Study Completion Date

July 5, 2018

Conditions
Bioequivalence of Two Azilsartan Formulations
Interventions
DRUG

Azilsartan (Zhaoke)

Azilsartan 20mg tablets from Zhaoke

DRUG

Azilsartan (Takeda)

Azilva 20mg tablets from Takeda

Trial Locations (1)

000000

Phase I Clinical Trial Centre, Chinese University of Hong Kong, Hong Kong

Sponsors
All Listed Sponsors
collaborator

Zhaoke (Guangzhou) Pharmaceutical Limited

UNKNOWN

lead

Lee's Pharmaceutical Limited

INDUSTRY